ELIQUIS, a co-promote with Bristol Myers Squibb, is the #1 prescribed brand overall in the U.S. and the top-selling non-specialty drug in the industry. Internally, it’s the flagship brand for the Internal Medicine Business Unit and a key anchor brand for Pfizer Inc. ELIQUIS remains a double-digit growth brand with significant performance and patient impact expectations through 2028. The Senior Director, US Eliquis Payer Marketing Lead reports to the US Internal Medicine Lead and is responsible for driving the 2 critical components of the brand’s US payer efforts: the payer access strategy and the patient affordability strategy. In addition, the Lead will also collaborate with the Alliance on access-related issues across the HCP, Hospital, Consumer, and Health System channels. This leader will direct, coach, and motivate a small team of direct reports enabling strong payer channel and patient affordability strategies. They will also lead a matrixed and complex team of senior leaders in the US Eliquis Alliance with BMS and functional SMEs across Pfizer. This position requires an understanding of the rapidly-evolving payer environment, including implications due to the Inflation Reduction Act (IRA) and maximum fair price requirements. The recent changes in the US market require the Brand team to demonstrate the clinical and economic benefits of Eliquis and translate these benefits into multichannel promotional resources that reach customers via digital channels as well as through a variety of teams, including traditional Payer Account Management, Key Account Management, MO&A, and Alliance-wide sales forces.